Jorge Romaguera

Professor, Department of Lymphoma and Myeloma

MD Anderson Cancer Center · Houston, United States

About

Developed and refined the hyper-CVAD regimen for MCL at MD Anderson, one of the most widely used intensive frontline regimens for younger MCL patients.

Specialties

Frontline therapyHyper-CVADIntensive chemotherapy

Key Trials

Hyper-CVAD/rituximab MCL studies

Profile

https://faculty.mdanderson.org/profiles/jorge_romaguera.html